ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Circular mRNA Drugs Market Research Report 2026
Published Date: 2026-03-16
|
Report Code: QYRE-Auto-19X17563
Home | Market Reports | Science| Biological Sciences
Global Circular mRNA Drugs Market Research Report 2024
BUY CHAPTERS

Global Circular mRNA Drugs Market Research Report 2026

Code: QYRE-Auto-19X17563
Report
2026-03-16
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Orna Therapeutics
Chimera Therapeutics
CirCode
Therorna Inc.
EdiGene Inc
Torque Bio
Sail Biomedicines
Orbital Therapeutics
Aikang Pharmaceuticals
Curemed Bio

Circular mRNA Drugs Market

The global Circular mRNA Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Circular mRNA Drugs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In nature, circular RNA (circRNA) is ubiquitous in fungi, plants, insects, fish, and mammals, and even the genomes of some viruses are circular RNAs. Unlike linear mRNA, circular RNA is highly stable because its covalently closed ring structure protects it from exonuclease-mediated degradation. Therefore, vaccines based on circular mRNA have become a new vaccine option.
The North American market for Circular mRNA Drugs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Circular mRNA Drugs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Circular mRNA Drugs include Orna Therapeutics, Chimera Therapeutics, CirCode, Therorna, Edigene, Aikang Pharmaceuticals, Curemed Bio, Torque Bio, Sail Biomedicines, Orbital Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Circular mRNA Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Circular mRNA Drugs. The Circular mRNA Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Circular mRNA Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Circular mRNA Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Circular mRNA Drugs Market Report

Report Metric Details
Report Name Circular mRNA Drugs Market
Segment by Type
  • Preventive Medicine
  • Medicine
by Application
  • Infectious Disease
  • Cancer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Orna Therapeutics, Chimera Therapeutics, CirCode, Therorna, Edigene, Aikang Pharmaceuticals, Curemed Bio, Torque Bio, Sail Biomedicines, Orbital Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Circular mRNA Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Circular mRNA Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Circular mRNA Drugs Market report?

Ans: The main players in the Circular mRNA Drugs Market are Orna Therapeutics, Chimera Therapeutics, CirCode, Therorna, Edigene, Aikang Pharmaceuticals, Curemed Bio, Torque Bio, Sail Biomedicines, Orbital Therapeutics

What are the Application segmentation covered in the Circular mRNA Drugs Market report?

Ans: The Applications covered in the Circular mRNA Drugs Market report are Infectious Disease, Cancer, Others

What are the Type segmentation covered in the Circular mRNA Drugs Market report?

Ans: The Types covered in the Circular mRNA Drugs Market report are Preventive Medicine, Medicine

1 Circular mRNA Drugs Market Overview
1.1 Product Definition
1.2 Circular mRNA Drugs by Type
1.2.1 Global Circular mRNA Drugs Market Value by Type: 2025 vs 2032
1.2.2 Preventive Medicine
1.2.3 Medicine
1.3 Circular mRNA Drugs by Application
1.3.1 Global Circular mRNA Drugs Market Value by Application: 2025 vs 2032
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Global Circular mRNA Drugs Market Size Estimates and Forecasts
1.4.1 Global Circular mRNA Drugs Revenue 2021–2032
1.4.2 Global Circular mRNA Drugs Sales 2021–2032
1.4.3 Global Circular mRNA Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Circular mRNA Drugs Market Competition by Manufacturers
2.1 Global Circular mRNA Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Circular mRNA Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Circular mRNA Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Circular mRNA Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Circular mRNA Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Circular mRNA Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Circular mRNA Drugs, Date of Entry into the Industry
2.8 Global Circular mRNA Drugs Market Competitive Situation and Trends
2.8.1 Global Circular mRNA Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Circular mRNA Drugs Players Market Share by Revenue
2.8.3 Global Circular mRNA Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Circular mRNA Drugs Market Scenario by Region
3.1 Global Circular mRNA Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Circular mRNA Drugs Sales by Region: 2021–2032
3.2.1 Global Circular mRNA Drugs Sales by Region: 2021–2026
3.2.2 Global Circular mRNA Drugs Sales by Region: 2027–2032
3.3 Global Circular mRNA Drugs Revenue by Region: 2021–2032
3.3.1 Global Circular mRNA Drugs Revenue by Region: 2021–2026
3.3.2 Global Circular mRNA Drugs Revenue by Region: 2027–2032
3.4 North America Circular mRNA Drugs Market Facts & Figures by Country
3.4.1 North America Circular mRNA Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Circular mRNA Drugs Sales by Country (2021–2032)
3.4.3 North America Circular mRNA Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Circular mRNA Drugs Market Facts & Figures by Country
3.5.1 Europe Circular mRNA Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Circular mRNA Drugs Sales by Country (2021–2032)
3.5.3 Europe Circular mRNA Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Circular mRNA Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Circular mRNA Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Circular mRNA Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Circular mRNA Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Circular mRNA Drugs Market Facts & Figures by Country
3.7.1 Latin America Circular mRNA Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Circular mRNA Drugs Sales by Country (2021–2032)
3.7.3 Latin America Circular mRNA Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Circular mRNA Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Circular mRNA Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Circular mRNA Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Circular mRNA Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Circular mRNA Drugs Sales by Type (2021–2032)
4.1.1 Global Circular mRNA Drugs Sales by Type (2021–2026)
4.1.2 Global Circular mRNA Drugs Sales by Type (2027–2032)
4.1.3 Global Circular mRNA Drugs Sales Market Share by Type (2021–2032)
4.2 Global Circular mRNA Drugs Revenue by Type (2021–2032)
4.2.1 Global Circular mRNA Drugs Revenue by Type (2021–2026)
4.2.2 Global Circular mRNA Drugs Revenue by Type (2027–2032)
4.2.3 Global Circular mRNA Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Circular mRNA Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Circular mRNA Drugs Sales by Application (2021–2032)
5.1.1 Global Circular mRNA Drugs Sales by Application (2021–2026)
5.1.2 Global Circular mRNA Drugs Sales by Application (2027–2032)
5.1.3 Global Circular mRNA Drugs Sales Market Share by Application (2021–2032)
5.2 Global Circular mRNA Drugs Revenue by Application (2021–2032)
5.2.1 Global Circular mRNA Drugs Revenue by Application (2021–2026)
5.2.2 Global Circular mRNA Drugs Revenue by Application (2027–2032)
5.2.3 Global Circular mRNA Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Circular mRNA Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Orna Therapeutics
6.1.1 Orna Therapeutics Company Information
6.1.2 Orna Therapeutics Description and Business Overview
6.1.3 Orna Therapeutics Circular mRNA Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Orna Therapeutics Circular mRNA Drugs Product Portfolio
6.1.5 Orna Therapeutics Recent Developments/Updates
6.2 Chimera Therapeutics
6.2.1 Chimera Therapeutics Company Information
6.2.2 Chimera Therapeutics Description and Business Overview
6.2.3 Chimera Therapeutics Circular mRNA Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Chimera Therapeutics Circular mRNA Drugs Product Portfolio
6.2.5 Chimera Therapeutics Recent Developments/Updates
6.3 CirCode
6.3.1 CirCode Company Information
6.3.2 CirCode Description and Business Overview
6.3.3 CirCode Circular mRNA Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CirCode Circular mRNA Drugs Product Portfolio
6.3.5 CirCode Recent Developments/Updates
6.4 Therorna
6.4.1 Therorna Company Information
6.4.2 Therorna Description and Business Overview
6.4.3 Therorna Circular mRNA Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Therorna Circular mRNA Drugs Product Portfolio
6.4.5 Therorna Recent Developments/Updates
6.5 Edigene
6.5.1 Edigene Company Information
6.5.2 Edigene Description and Business Overview
6.5.3 Edigene Circular mRNA Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Edigene Circular mRNA Drugs Product Portfolio
6.5.5 Edigene Recent Developments/Updates
6.6 Aikang Pharmaceuticals
6.6.1 Aikang Pharmaceuticals Company Information
6.6.2 Aikang Pharmaceuticals Description and Business Overview
6.6.3 Aikang Pharmaceuticals Circular mRNA Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Aikang Pharmaceuticals Circular mRNA Drugs Product Portfolio
6.6.5 Aikang Pharmaceuticals Recent Developments/Updates
6.7 Curemed Bio
6.7.1 Curemed Bio Company Information
6.7.2 Curemed Bio Description and Business Overview
6.7.3 Curemed Bio Circular mRNA Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Curemed Bio Circular mRNA Drugs Product Portfolio
6.7.5 Curemed Bio Recent Developments/Updates
6.8 Torque Bio
6.8.1 Torque Bio Company Information
6.8.2 Torque Bio Description and Business Overview
6.8.3 Torque Bio Circular mRNA Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Torque Bio Circular mRNA Drugs Product Portfolio
6.8.5 Torque Bio Recent Developments/Updates
6.9 Sail Biomedicines
6.9.1 Sail Biomedicines Company Information
6.9.2 Sail Biomedicines Description and Business Overview
6.9.3 Sail Biomedicines Circular mRNA Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Sail Biomedicines Circular mRNA Drugs Product Portfolio
6.9.5 Sail Biomedicines Recent Developments/Updates
6.10 Orbital Therapeutics
6.10.1 Orbital Therapeutics Company Information
6.10.2 Orbital Therapeutics Description and Business Overview
6.10.3 Orbital Therapeutics Circular mRNA Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Orbital Therapeutics Circular mRNA Drugs Product Portfolio
6.10.5 Orbital Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Circular mRNA Drugs Industry Chain Analysis
7.2 Circular mRNA Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Circular mRNA Drugs Production Mode & Process Analysis
7.4 Circular mRNA Drugs Sales and Marketing
7.4.1 Circular mRNA Drugs Sales Channels
7.4.2 Circular mRNA Drugs Distributors
7.5 Circular mRNA Drugs Customer Analysis
8 Circular mRNA Drugs Market Dynamics
8.1 Circular mRNA Drugs Industry Trends
8.2 Circular mRNA Drugs Market Drivers
8.3 Circular mRNA Drugs Market Challenges
8.4 Circular mRNA Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Orna Therapeutics
Chimera Therapeutics
CirCode
Therorna Inc.
EdiGene Inc
Torque Bio
Sail Biomedicines
Orbital Therapeutics
Aikang Pharmaceuticals
Curemed Bio
List of Tables
 Table 1. Global Circular mRNA Drugs Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Circular mRNA Drugs Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Circular mRNA Drugs Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Circular mRNA Drugs Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Circular mRNA Drugs Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Circular mRNA Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Circular mRNA Drugs Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Circular mRNA Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Circular mRNA Drugs, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Circular mRNA Drugs, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Circular mRNA Drugs, Product Types and Applications
 Table 12. Global Key Manufacturers of Circular mRNA Drugs, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Circular mRNA Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Circular mRNA Drugs Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Circular mRNA Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Circular mRNA Drugs Sales by Region (K Units), 2021–2026
 Table 18. Global Circular mRNA Drugs Sales Market Share by Region (2021–2026)
 Table 19. Global Circular mRNA Drugs Sales by Region (K Units), 2027–2032
 Table 20. Global Circular mRNA Drugs Sales Market Share by Region (2027–2032)
 Table 21. Global Circular mRNA Drugs Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Circular mRNA Drugs Revenue Market Share by Region (2021–2026)
 Table 23. Global Circular mRNA Drugs Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Circular mRNA Drugs Revenue Market Share by Region (2027–2032)
 Table 25. North America Circular mRNA Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Circular mRNA Drugs Sales by Country (K Units), 2021–2026
 Table 27. North America Circular mRNA Drugs Sales by Country (K Units), 2027–2032
 Table 28. North America Circular mRNA Drugs Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Circular mRNA Drugs Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Circular mRNA Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Circular mRNA Drugs Sales by Country (K Units), 2021–2026
 Table 32. Europe Circular mRNA Drugs Sales by Country (K Units), 2027–2032
 Table 33. Europe Circular mRNA Drugs Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Circular mRNA Drugs Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Circular mRNA Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Circular mRNA Drugs Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Circular mRNA Drugs Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Circular mRNA Drugs Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Circular mRNA Drugs Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Circular mRNA Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Circular mRNA Drugs Sales by Country (K Units), 2021–2026
 Table 42. Latin America Circular mRNA Drugs Sales by Country (K Units), 2027–2032
 Table 43. Latin America Circular mRNA Drugs Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Circular mRNA Drugs Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Circular mRNA Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Circular mRNA Drugs Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Circular mRNA Drugs Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Circular mRNA Drugs Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Circular mRNA Drugs Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Circular mRNA Drugs Sales (K Units) by Type (2021–2026)
 Table 51. Global Circular mRNA Drugs Sales (K Units) by Type (2027–2032)
 Table 52. Global Circular mRNA Drugs Sales Market Share by Type (2021–2026)
 Table 53. Global Circular mRNA Drugs Sales Market Share by Type (2027–2032)
 Table 54. Global Circular mRNA Drugs Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Circular mRNA Drugs Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Circular mRNA Drugs Revenue Market Share by Type (2021–2026)
 Table 57. Global Circular mRNA Drugs Revenue Market Share by Type (2027–2032)
 Table 58. Global Circular mRNA Drugs Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Circular mRNA Drugs Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Circular mRNA Drugs Sales (K Units) by Application (2021–2026)
 Table 61. Global Circular mRNA Drugs Sales (K Units) by Application (2027–2032)
 Table 62. Global Circular mRNA Drugs Sales Market Share by Application (2021–2026)
 Table 63. Global Circular mRNA Drugs Sales Market Share by Application (2027–2032)
 Table 64. Global Circular mRNA Drugs Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Circular mRNA Drugs Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Circular mRNA Drugs Revenue Market Share by Application (2021–2026)
 Table 67. Global Circular mRNA Drugs Revenue Market Share by Application (2027–2032)
 Table 68. Global Circular mRNA Drugs Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Circular mRNA Drugs Price (US$/Unit) by Application (2027–2032)
 Table 70. Orna Therapeutics Company Information
 Table 71. Orna Therapeutics Description and Business Overview
 Table 72. Orna Therapeutics Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Orna Therapeutics Circular mRNA Drugs Product
 Table 74. Orna Therapeutics Recent Developments/Updates
 Table 75. Chimera Therapeutics Company Information
 Table 76. Chimera Therapeutics Description and Business Overview
 Table 77. Chimera Therapeutics Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Chimera Therapeutics Circular mRNA Drugs Product
 Table 79. Chimera Therapeutics Recent Developments/Updates
 Table 80. CirCode Company Information
 Table 81. CirCode Description and Business Overview
 Table 82. CirCode Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. CirCode Circular mRNA Drugs Product
 Table 84. CirCode Recent Developments/Updates
 Table 85. Therorna Company Information
 Table 86. Therorna Description and Business Overview
 Table 87. Therorna Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Therorna Circular mRNA Drugs Product
 Table 89. Therorna Recent Developments/Updates
 Table 90. Edigene Company Information
 Table 91. Edigene Description and Business Overview
 Table 92. Edigene Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Edigene Circular mRNA Drugs Product
 Table 94. Edigene Recent Developments/Updates
 Table 95. Aikang Pharmaceuticals Company Information
 Table 96. Aikang Pharmaceuticals Description and Business Overview
 Table 97. Aikang Pharmaceuticals Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Aikang Pharmaceuticals Circular mRNA Drugs Product
 Table 99. Aikang Pharmaceuticals Recent Developments/Updates
 Table 100. Curemed Bio Company Information
 Table 101. Curemed Bio Description and Business Overview
 Table 102. Curemed Bio Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Curemed Bio Circular mRNA Drugs Product
 Table 104. Curemed Bio Recent Developments/Updates
 Table 105. Torque Bio Company Information
 Table 106. Torque Bio Description and Business Overview
 Table 107. Torque Bio Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Torque Bio Circular mRNA Drugs Product
 Table 109. Torque Bio Recent Developments/Updates
 Table 110. Sail Biomedicines Company Information
 Table 111. Sail Biomedicines Description and Business Overview
 Table 112. Sail Biomedicines Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Sail Biomedicines Circular mRNA Drugs Product
 Table 114. Sail Biomedicines Recent Developments/Updates
 Table 115. Orbital Therapeutics Company Information
 Table 116. Orbital Therapeutics Description and Business Overview
 Table 117. Orbital Therapeutics Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Orbital Therapeutics Circular mRNA Drugs Product
 Table 119. Orbital Therapeutics Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Circular mRNA Drugs Distributors List
 Table 123. Circular mRNA Drugs Customers List
 Table 124. Circular mRNA Drugs Market Trends
 Table 125. Circular mRNA Drugs Market Drivers
 Table 126. Circular mRNA Drugs Market Challenges
 Table 127. Circular mRNA Drugs Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Circular mRNA Drugs
 Figure 2. Global Circular mRNA Drugs Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Circular mRNA Drugs Market Share by Type: 2025 & 2032
 Figure 4. Preventive Medicine Product Picture
 Figure 5. Medicine Product Picture
 Figure 6. Global Circular mRNA Drugs Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Circular mRNA Drugs Market Share by Application: 2025 & 2032
 Figure 8. Infectious Disease
 Figure 9. Cancer
 Figure 10. Others
 Figure 11. Global Circular mRNA Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Circular mRNA Drugs Market Size (US$ Million), 2021–2032
 Figure 13. Global Circular mRNA Drugs Sales (K Units), 2021–2032
 Figure 14. Global Circular mRNA Drugs Average Price (US$/Unit), 2021–2032
 Figure 15. Circular mRNA Drugs Report Years Considered
 Figure 16. Circular mRNA Drugs Sales Share by Manufacturers in 2025
 Figure 17. Global Circular mRNA Drugs Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Circular mRNA Drugs Players: Market Share by Revenue in Circular mRNA Drugs in 2025
 Figure 19. Circular mRNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Circular mRNA Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Circular mRNA Drugs Sales Market Share by Country (2021–2032)
 Figure 22. North America Circular mRNA Drugs Revenue Market Share by Country (2021–2032)
 Figure 23. United States Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Circular mRNA Drugs Sales Market Share by Country (2021–2032)
 Figure 26. Europe Circular mRNA Drugs Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Circular mRNA Drugs Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Circular mRNA Drugs Revenue Market Share by Region (2021–2032)
 Figure 34. China Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Circular mRNA Drugs Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Circular mRNA Drugs Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Circular mRNA Drugs Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Circular mRNA Drugs Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Circular mRNA Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Circular mRNA Drugs by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Circular mRNA Drugs by Type (2021–2032)
 Figure 54. Global Circular mRNA Drugs Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Circular mRNA Drugs by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Circular mRNA Drugs by Application (2021–2032)
 Figure 57. Global Circular mRNA Drugs Price (US$/Unit) by Application (2021–2032)
 Figure 58. Circular mRNA Drugs Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Circular RNA Therapy Market Research Report 2024
Global circRNAs Treatment Market Research Report 2024
Global Circular RNA Research Market Insights Forecast to 2030
Global Circular RNA Drugs Market Research Report 2025
Global Exogenous Circular RNA Synthesis Service Market Research Report 2025
Global ircular RNA Synthesis Service Market Research Report 2024
Global CircRNA Synthesis Service Market Research Report 2024
Global Circular RNA Synthesis Kit Market Research Report 2024
Global Circular RNA Sequencing Market Insights Forecast to 2030
Global RNA Vaccines Market Insights Forecast to 2030
Global circRNA Technology Market Research Report 2024
Global mRNA Vaccines Therapeutics Market Research Report 2024
Global RNA Stabilizers Market Research Report 2024
Global Veterinary mRNA Vaccines Market Research Report 2025
Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030
Global circRNA LNP Formulation Market Research Report 2024
Global MicroRNA Market Research Report 2024
Global Self amplifying RNA saRNA Drugs Market Research Report 2024
Global miRNA Sequencing and Assay Market Insights Forecast to 2030
mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions